{"schema_version":"secwatch.filing_event.v1","accession":"0002007919-26-000002","form_type":"8-K","ticker":"INBX","cik":"0002007919","company_name":"Inhibrx Biosciences, Inc.","filed_at":"2026-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.978752+00:00","generated_at":"2026-05-16T01:16:38.429578+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Inhibrx publishes updated corporate presentation on investor website","bullets":["Presentation posted February 23, 2026 under the Investors tab of www.inhibrx.com.","Filing includes only presentation disclaimer; substantive pipeline and financial details not accessible in this report.","Company routinely updates this presentation for conferences and meetings; no specific material changes disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0002007919-26-000002","json":"https://secwatch.observer/filing/0002007919-26-000002.json","markdown":"https://secwatch.observer/filing/0002007919-26-000002.md","text":"https://secwatch.observer/filing/0002007919-26-000002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2007919/000200791926000002/0002007919-26-000002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2007919/000200791926000002/inhibrx-20260223.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T01:16:38.429578+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}